Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Aricept vs. Namzaric

Are Aricept and Namzaric the Same Thing?

Aricept (donepezil hydrochloride) and Namzaric (memantine hydrochloride extended-release and donepezil hydrochloride) are used to reduce symptoms of mild to moderate dementia like that found in patients with Alzheimer's disease.

Aricept and Namzaric are different types of drugs. Aricept is a cholinesterase inhibitor and Namzaric is a combination of an orally active NMDA receptor antagonist and a cholinesterase inhibitor.

Side effects of Aricept and Namzaric that are similar include drowsiness/sleepiness, dizziness, vomiting, or diarrhea.

Side effects of Aricept that are different from Namzaric include feeling unwell (malaise), appetite loss, weight loss, sleep problems (insomnia), muscle cramps, weakness, shakiness (tremor), itchy skin, or nausea.

Side effects of Namzaric that are different from Aricept include headache, flu symptoms, anxiety, high or low blood pressure, constipation, abdominal pain, weight gain, back pain, depression, aggression, and urinary incontinence.

Both Aricept and Namzaric may interact with anticholinergic medications, succinylcholine or similar neuromuscular blocking agents, or cholinergic agonists.

What Are Possible Side Effects of Aricept?

Common side effects of Aricept include:

  • feeling unwell (malaise),
  • appetite loss,
  • weight loss,
  • sleep problems (insomnia),
  • muscle cramps,
  • tiredness,
  • drowsiness,
  • dizziness,
  • weakness,
  • shakiness (tremor),
  • itchy skin,
  • nausea,
  • vomiting, or
  • diarrhea.

Tell your doctor if you experience serious side effects of Aricept including painful urination, seizures, chest pain, and GI symptoms of tarry or bloody stools and vomiting blood or material that resembles "coffee grounds."

What Are Possible Side Effects of Namzaric?

Common side effects of Namzaric include:

What is Aricept?

Aricept (donepezil hydrochloride) is a cholinesterase inhibitor that reduces or prevents acetylcholine breakdown in brain tissue. Aricept is used to treat mild to moderate dementia like that found in patients with Alzheimer's disease. Aricept is not a cure; it reduces symptoms.

What is Namzaric?

Namzaric (memantine hydrochloride extended-release and donepezil hydrochloride) is a combination of an orally active NMDA receptor antagonist, and a reversible inhibitor of the enzyme acetylcholinesterase, used to treat moderate to severe dementia of the Alzheimer's type in patients stabilized on memantine hydrochloride and donepezil hydrochloride.

SLIDESHOW

Dementia, Alzheimer's Disease, and Aging Brains See Slideshow

What Drugs Interact With Aricept?

Aricept may interact with many drugs; tell the physician if you have a history of breathing problems, heart disease, fainting, seizures, GI diseases or urinary problems because they may get worst with this drug. Aricept is not recommended for use in pregnant or breastfeeding women. Aricept safety and effectiveness has not been studied in the pediatric population.

What Drugs Interact With Namzaric?

Namzaric may interact with NMDA antagonists, anticholinergics, succinylcholine, similar neuromuscular blocking agents, or cholinergic agonists.

How Should Aricept Be Taken?

Aricept (donepezil hydrochloride) is available for oral administration in film-coated tablets in doses of 5, 10, or 23 mg of donepezil hydrochloride.

How Should Namzaric Be Taken?

Patients stabilized on memantine hydrochloride and donepezil hydrochloride can be switched to Namzaric 28 mg/10 mg, taken once a day in the evening.

QUESTION

One of the first symptoms of Alzheimer's disease is __________________. See Answer

From WebMD Logo

Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
SOURCE:

Eisai R&D Management Co., Ltd. Aricept Product Information.

http://www.aricept.com/

Allergan. Namzaric Product Information.

http://www.namzaric.com

Health Solutions From Our Sponsors